RecallDepth
Class III Ongoing

Estradiol Transdermal System, USP (Twice-Weekly) 0.0375mg/day, Rx Only, Manufactured by: Cadila Healthcare Limited, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1192-8

This recall is currently active, issued June 12, 2024. It was issued by Zydus Pharmaceuticals (Usa) Inc.

Company
Zydus Pharmaceuticals (Usa) Inc
Recall Initiated
May 16, 2024
Posted
June 12, 2024
Recall Number
D-0542-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
21,360 units
Firm Location
Pennington, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Impurities/Degradation Specifications.

Distribution

Nationwide within the United States

Lot / Code Info

Lot #: M310493, Exp. Date 01/2025; M308397, Exp. Date 11/2024; M305337, Exp. Date 10/2024; M400155, Exp. Date 06/2025; M314660, Exp. Date 05/2025

More recalls by Zydus Pharmaceuticals (Usa) Inc

View all recalls by this company →

Other recent Class III Drug recalls